Publications: Ancliffe, Mathew

Journal Article

Abbas, Z., George, C., Ancliffe, M., Howlett, M., Jones, A.C., Kuchibhotla, M., Wechsler-Reya, R.J., Gottardo, N.G. and Endersby, R. (2022) Conventional therapies deplete Brain-Infiltrating adaptive immune cells in a Mouse Model of Group 3 Medulloblastoma implicating Myeloid Cells as favorable immunotherapy targets. Frontiers in Immunology, 13 . Art. 837013.

Abbas, Z., Howlett, M., Buck, J., Hii, H., Kuchibhotla, M., Ancliffe, M., Whitehouse, J., Johns, T., Ebert, M., Gottardo, N. and Endersby, R. (2022) JS04.5.A Enhancing the activity of anti-CD47 antibody therapy with radiotherapy in preclinical models of medulloblastoma. Neuro-Oncology, 24 (Supplement_2). ii7.

Abbas, Z., Buck, J., Ancliffe, M., Arias, C.A., Howlett, M., Hii, H., Johns, T., Mitra, S., Gottardo, N. and Endersby, R. (2022) MODL-18. Enhancing anti-CD47 mAb efficacy with radiotherapy for Group 3 paediatric medulloblastoma in preclinical models. Neuro-Oncology, 24 (Supp. 1). i172-i173.

Andradas, C., Byrne, J., Kuchibhotla, M., Ancliffe, M., Jones, A.C., Carline, B., Hii, H., Truong, A., Storer, L.C.D., Ritzmann, T.A., Grundy, R.G., Gottardo, N.G. and Endersby, R. (2021) Assessment of cannabidiol and Δ9-Tetrahydrocannabiol in mouse models of Medulloblastoma and Ependymoma. Cancers, 13 (2). Art. 330.